These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

658 related articles for article (PubMed ID: 10213798)

  • 1. Ligands for the benzodiazepine binding site--a survey.
    Teuber L; Wätjens F; Jensen LH
    Curr Pharm Des; 1999 May; 5(5):317-43. PubMed ID: 10213798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medicinal chemistry of indolylglyoxylamide GABAA/BzR high affinity ligands: identification of novel anxiolytic/non sedative agents.
    Salerno S; Da Settimo F; Taliani S; Simorini F; La Motta C; Fornaciari G; Marini AM
    Curr Top Med Chem; 2012; 12(4):286-311. PubMed ID: 22204484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anxioselective compounds acting at the GABA(A) receptor benzodiazepine binding site.
    Atack JR
    Curr Drug Targets CNS Neurol Disord; 2003 Aug; 2(4):213-32. PubMed ID: 12871032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of GABAA receptor structure and function by chronic drug treatments in vivo and with stably transfected cells.
    Klein RL; Harris RA
    Jpn J Pharmacol; 1996 Jan; 70(1):1-15. PubMed ID: 8822084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The GABAA-BZR complex as target for the development of anxiolytic drugs.
    Trincavelli ML; Da Pozzo E; Daniele S; Martini C
    Curr Top Med Chem; 2012; 12(4):254-69. PubMed ID: 22204488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization in rats of the anxiolytic potential of ELB139 [1-(4-chlorophenyl)-4-piperidin-1-yl-1,5-dihydro-imidazol-2-on], a new agonist at the benzodiazepine binding site of the GABAA receptor.
    Langen B; Egerland U; Bernöster K; Dost R; Unverferth K; Rundfeldt C
    J Pharmacol Exp Ther; 2005 Aug; 314(2):717-24. PubMed ID: 15860576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GABAA-receptor expressed from rat brain alpha- and beta-subunit cDNAs displays potentiation by benzodiazepine receptor ligands.
    Malherbe P; Draguhn A; Multhaup G; Beyreuther K; Möhler H
    Brain Res Mol Brain Res; 1990 Aug; 8(3):199-208. PubMed ID: 1977069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological modulation of the diazepam-insensitive recombinant gamma-aminobutyric acidA receptors alpha 4 beta 2 gamma 2 and alpha 6 beta 2 gamma 2.
    Knoflach F; Benke D; Wang Y; Scheurer L; Lüddens H; Hamilton BJ; Carter DB; Mohler H; Benson JA
    Mol Pharmacol; 1996 Nov; 50(5):1253-61. PubMed ID: 8913357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacology of the human gamma-aminobutyric acidA receptor alpha 4 subunit expressed in Xenopus laevis oocytes.
    Whittemore ER; Yang W; Drewe JA; Woodward RM
    Mol Pharmacol; 1996 Nov; 50(5):1364-75. PubMed ID: 8913369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GABAA receptor subtypes: autoradiographic comparison of GABA, benzodiazepine, and convulsant binding sites in the rat central nervous system.
    Olsen RW; McCabe RT; Wamsley JK
    J Chem Neuroanat; 1990; 3(1):59-76. PubMed ID: 2156526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GABA-A receptors: a viable target for novel anxiolytics?
    Whiting PJ
    Curr Opin Pharmacol; 2006 Feb; 6(1):24-9. PubMed ID: 16359919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular and pharmacological characterization of GABA(A) receptor alpha1 subunit knockout mice.
    Kralic JE; Korpi ER; O'Buckley TK; Homanics GE; Morrow AL
    J Pharmacol Exp Ther; 2002 Sep; 302(3):1037-45. PubMed ID: 12183661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The diversity of GABAA receptors. Pharmacological and electrophysiological properties of GABAA channel subtypes.
    Hevers W; Lüddens H
    Mol Neurobiol; 1998 Aug; 18(1):35-86. PubMed ID: 9824848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased brain concentrations of endogenous (non-benzodiazepine) GABA-A receptor ligands in human hepatic encephalopathy.
    Ahboucha S; Pomier-Layrargues G; Butterworth RF
    Metab Brain Dis; 2004 Dec; 19(3-4):241-51. PubMed ID: 15554420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [GABA(A) benzodiazepine receptors and epilepsy].
    Sieghart W
    Wien Klin Wochenschr; 1990 Mar; 102(7):197-201. PubMed ID: 2160756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacology of the benzodiazepine receptor.
    Haefely WE
    Eur Arch Psychiatry Neurol Sci; 1989; 238(5-6):294-301. PubMed ID: 2569974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benzodiazepine interactions with GABA receptors.
    Haefely W
    Neurosci Lett; 1984 Jun; 47(3):201-6. PubMed ID: 6147796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allosteric ligands and their binding sites define γ-aminobutyric acid (GABA) type A receptor subtypes.
    Olsen RW
    Adv Pharmacol; 2015; 73():167-202. PubMed ID: 25637441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological characterization of a novel cell line expressing human alpha(4)beta(3)delta GABA(A) receptors.
    Brown N; Kerby J; Bonnert TP; Whiting PJ; Wafford KA
    Br J Pharmacol; 2002 Aug; 136(7):965-74. PubMed ID: 12145096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in agonist/antagonist binding affinity and receptor transduction using recombinant human gamma-aminobutyric acid type A receptors.
    Ebert B; Thompson SA; Saounatsou K; McKernan R; Krogsgaard-Larsen P; Wafford KA
    Mol Pharmacol; 1997 Dec; 52(6):1150-6. PubMed ID: 9396785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.